InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Explore the detailed record of transactions filed by Coffin Robert, Président et Responsable R&D. Insider active across 1 companies, notably Replimune Group, Inc.. Aggregated, 6 disclosures have been recorded. Total volume traded: €1.6m. The latest transaction was filed on 16 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€80,1835,737 shares@ €13.97650.019% mcap5.0% of flow
Common Stock
SEC:0001104659-22-062606:0·
026,250 shares0
Common Stock
SEC:0001104659-22-042771:0·
€263,9767,810 shares@ €33.79980.061% mcap34.9% of flow
Common Stock
SEC:0001104659-21-089919·
€263,9767,810 shares@ €33.79980.061% mcap16.6% of flow
Common Stock
SEC:0001104659-21-089919:0·
€492,17114,663 shares@ €33.56550.11% mcap65.1% of flow
Common Stock
SEC:0001104659-21-087803·
€492,17114,663 shares@ €33.56550.11% mcap30.9% of flow
Common Stock
SEC:0001104659-21-087803:0·
6 of 6 declarations
About Coffin Robert
Robert Coffin is President & Chief R&D Officer at Replimune Group, Inc. He is responsible for leading the company's research and development efforts. His role is essential in guiding innovation initiatives and product development.
